ONWARD® MEDICAL ANNOUNCES PRESENTATION AT BIOCAPITAL EUROPE
EINDHOVEN, the Netherlands, Feb. 07, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces its participation in BioCapital Europe in Amsterdam on February 8, 2024.
- EINDHOVEN, the Netherlands, Feb. 07, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces its participation in BioCapital Europe in Amsterdam on February 8, 2024.
- The event, one of Europe’s leading life sciences investor conferences, is organized by life sciences venture capital fund EQT Life Sciences, an investor in ONWARD Medical.
- ONWARD Medical CEO Dave Marver will present and participate in 1:1 and group meetings with investors during the conference.
- *All ONWARD Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.